PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 122 filers reported holding PMV PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $328,306 | +6.8% | 53,470 | +8.9% | 0.00% | – |
| Q2 2023 | $307,303 | +38.5% | 49,090 | +5.6% | 0.00% | – |
| Q1 2023 | $221,805 | -38.3% | 46,500 | +12.6% | 0.00% | – |
| Q4 2022 | $359,310 | -26.8% | 41,300 | 0.0% | 0.00% | – |
| Q3 2022 | $491,000 | +7.9% | 41,300 | +29.5% | 0.00% | – |
| Q2 2022 | $455,000 | +32.3% | 31,900 | +93.3% | 0.00% | – |
| Q1 2022 | $344,000 | -9.7% | 16,500 | 0.0% | 0.00% | – |
| Q4 2021 | $381,000 | -3.1% | 16,500 | +25.0% | 0.00% | – |
| Q3 2021 | $393,000 | -40.7% | 13,200 | -32.0% | 0.00% | – |
| Q2 2021 | $663,000 | +105.9% | 19,400 | +98.0% | 0.00% | – |
| Q1 2021 | $322,000 | -43.7% | 9,800 | +5.4% | 0.00% | – |
| Q4 2020 | $572,000 | – | 9,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
| Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
| OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
| Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
| Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
| Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
| Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
| RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
| HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |